日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

在HGF主导的乳腺癌环境中,致癌MET和PIK3CA的协同作用

Liu, Shuying; Li, Shunqiang; Wang, Bailiang; Liu, Wenbin; Gagea, Mihai; Chen, Huiqin; Sohn, Joohyuk; Parinyanitikul, Napa; Primeau, Tina; Do, Kim-Anh; Vande Woude, George F; Mendelsohn, John; Ueno, Naoto T; Mills, Gordon B; Tripathy, Debu; Gonzalez-Angulo, Ana M

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

利用生物标志物指导早期浸润性乳腺癌女性辅助全身治疗决策:美国临床肿瘤学会临床实践指南

Harris, Lyndsay N; Ismaila, Nofisat; McShane, Lisa M; Andre, Fabrice; Collyar, Deborah E; Gonzalez-Angulo, Ana M; Hammond, Elizabeth H; Kuderer, Nicole M; Liu, Minetta C; Mennel, Robert G; Van Poznak, Catherine; Bast, Robert C; Hayes, Daniel F

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

利用生物标志物指导转移性乳腺癌女性患者全身治疗决策:美国临床肿瘤学会临床实践指南

Van Poznak, Catherine; Somerfield, Mark R; Bast, Robert C; Cristofanilli, Massimo; Goetz, Matthew P; Gonzalez-Angulo, Ana M; Hicks, David G; Hill, Elizabeth G; Liu, Minetta C; Lucas, Wanda; Mayer, Ingrid A; Mennel, Robert G; Symmans, William F; Hayes, Daniel F; Harris, Lyndsay N

Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases

验证和开发改良的乳腺分级预后评估方法,作为乳腺癌脑转移患者生存评估的工具

Subbiah, Ishwaria M; Lei, Xiudong; Weinberg, Jeffrey S; Sulman, Erik P; Chavez-MacGregor, Mariana; Tripathy, Debu; Gupta, Rohan; Varma, Ankur; Chouhan, Jay; Guevarra, Richard P; Valero, Vicente; Gilbert, Mark R; Gonzalez-Angulo, Ana M

Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer

伊沙匹隆与观察组治疗HER2阴性乳腺癌新辅助全身治疗后存在显著残留病灶患者的II期随机研究

Gonzalez-Angulo, Ana M; Lei, Xiudong; Alvarez, Richardo H; Green, Majorie C; Murray, James L; Valero, Vicente; Koenig, Kimberly B; Ibrahim, Nuhad K; Litton, Jennifer K; Nair, Lakshmy; Krishnamurthy, Savitri; Hortobagyi, Gabriel N; Meric-Bernstam, Funda

Effect of 21-Gene RT-PCR Assay on Adjuvant Therapy and Outcomes in Patients With Stage I Breast Cancer

21基因RT-PCR检测对I期乳腺癌患者辅助治疗及预后的影响

Le Du, Fanny; Gonzalez-Angulo, Ana M; Park, Minjeong; Liu, Diane D; Hortobagyi, Gabriel N; Ueno, Naoto T

Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy

新辅助HER2靶向治疗时代炎性乳腺癌多学科治疗后的疗效

Tsai, Chiaojung Jillian; Li, Jing; Gonzalez-Angulo, Ana M; Allen, Pamela K; Woodward, Wendy A; Ueno, Naoto T; Lucci, Anthony; Krishnamurthy, Savitri; Gong, Yun; Yang, Wei; Cristofanilli, Massimo; Valero, Vicente; Buchholz, Thomas A

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?

三阴性乳腺癌个性化治疗的未来是否取决于分子亚型?

Le Du, Fanny; Eckhardt, Bedrich L; Lim, Bora; Litton, Jennifer K; Moulder, Stacy; Meric-Bernstam, Funda; Gonzalez-Angulo, Ana M; Ueno, Naoto T

Functional consequence of the MET-T1010I polymorphism in breast cancer.

MET-T1010I多态性在乳腺癌中的功能后果

Liu Shuying, Meric-Bernstam Funda, Parinyanitikul Napa, Wang Bailiang, Eterovic Agda K, Zheng Xiaofeng, Gagea Mihai, Chavez-MacGregor Mariana, Ueno Naoto T, Lei Xiudong, Zhou Wanding, Nair Lakshmy, Tripathy Debu, Brown Powel H, Hortobagyi Gabriel N, Chen Ken, Mendelsohn John, Mills Gordon B, Gonzalez-Angulo Ana M

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study

肿瘤亚型和治疗模式对小型淋巴结阴性乳腺癌女性患者预后的影响:一项多中心研究

Vaz-Luis, Ines; Ottesen, Rebecca A; Hughes, Melissa E; Mamet, Rizvan; Burstein, Harold J; Edge, Stephen B; Gonzalez-Angulo, Ana M; Moy, Beverly; Rugo, Hope S; Theriault, Richard L; Weeks, Jane C; Winer, Eric P; Lin, Nancy U